| 17.09. | MERCK : le CHMP approuve le Keytruda pour des cancers du sein |  |
| 17.09. | MERCK : Receives Positive Opinion for Keytruda, Chemotherapy Combination From Eu.. |  |
| 17.09. | MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) in Combi.. | |
| 17.09. | Merck Gets CHMP Backing of Keytruda in Triple-Negative Breast Cancer | |
| 17.09. | MERCK : EquiTrace wins Best Start-Up Award & new Best Vet Tech Award at the Inno.. | |
| 16.09. | SILVERBACK THERAPEUTICS : Reports Early Data From Phase 1/1b Study of SBT6050 in.. | |
| 16.09. | HOOKIPA PHARMA : announces clinical collaboration with Merck & Co., Inc., Kenilw.. | |
| 16.09. | BIOXCEL THERAPEUTICS : Says Therapeutics Study Shows Anti-Tumor Activity of Pros.. | |
| 16.09. | BIOCORP and MERCK Sign a Partnership in the Field of Human Growth Hormone | |
| 15.09. | HOOKIPA PHARMA : Merck Collaborate on Head, Neck Cancer Combo Therapy Developmen.. | |
| 15.09. | HOOKIPA Pharma Inc. Announces Clinical Collaboration with Merck & Co., Inc., .. | |
| 15.09. | Hookipa Working With Merck in Advanced Head and Neck Cancers | |
| 14.09. | IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 .. | |
| 13.09. | Merck sees potential U.S. authorization for COVID-19 antiviral before year-en.. | |
| 13.09. | MERCK & C : mpany CEO Expects Clinical Data on Covid Vaccine in H2 2021, Possibl.. | |
| 13.09. | MERCK : Cooley Continues Life Sciences Partnering Growth On East Coast | |
| 09.09. | Codexis, Inc. and Merck Amend and Extend License and Supply Agreement for Enz.. | |
| 09.09. | U.S. government to tackle Medicare drug payments to try to cut costs | |
| 09.09. | PDS BIOTECHNOLOGY : Completes Recruitment in Safety Cohort of Phase 2 Study of H.. | |
| 09.09. | MERCK : les prévisions de croissance de Life Science revues à la hausse | |
| 09.09. | PLANÈTE BOURSE : La revue de presse du jeudi 9 septembre 2021 | |
| 08.09. | MERCK : To Present New Data From Its Broad Oncology Portfolio and Pipeline at ES.. | |
| 08.09. | Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at E.. | |
| 07.09. | Illumina, Merck to Collaborate Over Diagnostic Tests For Cancer Mutations | |
| 07.09. | MERCK : recul du titre, un broker dégrade son opinion | |
| 07.09. | MERCK : Morgan Stanley dégrade sa recommandation | |
| 07.09. | MERCK : nouvelle approbation du Keytruda en Chine | |
| 07.09. | Today on Wall Street: Back to business | |
| 07.09. | ANALYST RECOMMENDATIONS : Amgen, Banner, Merck, Oracle, Phoenix... | |
| 07.09. | MERCK : Says Keytruda is Now Approved for Additional Indication of Carcinoma in .. | |
| 07.09. | MERCK : to Present at the Morgan Stanley 19th Annual Healthcare Conference | |
| 07.09. | MERCK : KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemothe.. | |
| 07.09. | Merck’s Keytruda (Pembrolizumab) Approves in China in Combination with Chemot.. | |
| 01.09. | GLOBAL MARKETS LIVE : Getlink, Intuit, CrowdStrike, Xiaomi, Merck... | |
| 01.09. | IMMUTEP : Completes Patient Enrollment in Stage 2 of Part B of NSCLC Study; Shar.. | |
| 01.09. | MERCK : démarrage d'un essai dans la Covid-19 | |
| 01.09. | MERCK : Ridgeback Biotherapeutics Launch Phase 3 Trial of Potential COVID-19 Ant.. | |
| 01.09. | MERCK : and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOV.. | |
| 01.09. | Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MO.. | |
| 01.09. | Merck, Ridgeback Launch Phase 3 Trial of Covid-19 Prophylactic | |
| 01.09. | IMMUTEP : Completes Recruitment, Dosing in Phase 2 Trial of Non-Small Cell Lung .. | |
| 01.09. | BÖRSE MADRID : El apoyo, cuando nos retienen |  |
| 01.09. | BÖRSE PARIS : Soutien, quand tu nous tiens | |
| 01.09. | EN DIRECT DES MARCHES : Carrefour, Engie, Pernod Ricard, BioMérieux, Medincell, .. | |
| 31.08. | MERCK : Secures FDA Full Approval for Updated Indication for Keytruda to Treat B.. | |
| 31.08. | MERCK : FDA Approves Updated Indication for Merck's KEYTRUDA® (pembrolizumab) fo.. | |
| 31.08. | Merck Announces Label Update for Keytruda, Merck’s Anti-PD-1 Therapy, for Its.. | |
| 27.08. | OSE IMMUNOTHERAPEUTICS : Enrolls First Patient in Phase 2 Study of Ovarian Cance.. | |
| 26.08. | MERCK : deux nouvelles indications pour Keytruda au Japon | |
| 26.08. | MERCK : Keytruda Wins Two New Japanese Approvals | |
| 26.08. | MERCK : KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan | |
| 26.08. | Merck’s Keytruda (Pembrolizumab) Receives Two New Approvals in Japan | |
| 25.08. | MERCK : résultats positifs pour Vaxneuvance chez les bébés | |
| 25.08. | MERCK : Pneumococcal Vaccine Meets Safety Endpoints in Trial Reviewing Use in In.. | |
| 25.08. | Warren Buffett's latest shopping spree | |
| 25.08. | MERCK : Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) .. | |
| 25.08. | Merck & Co., Inc. Announces Topline Results from the Pivotal PNEU-PED (V114-0.. | |
| 25.08. | Merck's Vaxneuvance Hits Key Endpoints in Infant Study | |
| 24.08. | Les dernières emplettes de Warren Buffett | |
| 23.08. | MERCK : Leslie A. Brun Resigns from Merck Board of Directors | |
| 23.08. | MERCK : WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson | |
| 23.08. | MERCK : un administrateur indépendant quitte le conseil | |
| 20.08. | MERCK : Leslie A. Brun Resigns from Merck Board of Directors (Form 8-K) | |
| 20.08. | MERCK & CO., INC. : Financial Statements and Exhibits (form 8-K) | |
| 20.08. | Merck & Co., Inc. Announces Resignation of Leslie A. Brun as Board of Directo.. | |
| 20.08. | MERCK : Leslie A. Brun Resigns from Merck Board of Directors | |
| 19.08. | ADAGENE : Joins Forces With Merck for Study of Cancer Treatment Candidate ADG106.. | |
| 19.08. | Adagene Announces the Third Clinical Trial Collaboration with Merck to Advanc.. | |
| 18.08. | WEREWOLF THERAPEUTICS : Collaborates With Merck on Solid Tumor Program | |
| 18.08. | Werewolf Therapeutics Announces Clinical Trial Collaboration with Merck on it.. | |
| 18.08. | Werewolf to Study WTX-124 With Merck's Keytruda in Solid Tumors | |
| 17.08. | STREET COLOR : Berkshire Hathaway Takes New Position in Organon, Dumps Biogen, A.. | |
| 16.08. | MERCK : FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha (HIF-2?) Inhibitor.. | |
| 14.08. | MERCK : FDA Approves Merck's Hypoxia-Inducible Factor-2 Alpha (HIF-2α) Inh.. | |
| 14.08. | MERCK : Canada Initiates Rolling Submission to Health Canada for Molnupiravir, a.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
